Skip to Content


In the US, Lixisenatide (lixisenatide systemic) is a member of the drug class incretin mimetics and is used to treat Diabetes, Type 2.

US matches:



CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antidiabetic agent: Incretin-mimetic, glucagon-like peptide-1 (GLP-1) agonist

Chemical Name

des-38-proline-exendine-4 (Heloderma suspectum)-(1-39)-peptidylpenta-L-lysyl-L-lysinamide (WHO )

Foreign Names

  • Lixisenatidum (Latin)
  • Lixisenatid (German)
  • Lixisénatide (French)
  • Lixisenatida (Spanish)

Generic Names

  • Lixisenatide (OS: JAN)
  • AQVE-10010 (IS)
  • AVE 0010 (IS)
  • UNII-74O62BB01U (IS)
  • ZP 10 (IS)

Brand Names

  • Lyxumia
    Sanofi, Dominican Republic; Sanofi, United Kingdom; Sanofi, Guatemala; Sanofi, Ireland; Sanofi, Japan; Sanofi, Panama; Sanofi, Sweden; Sanofi Aventis, Spain; Sanofi Oy, Finland; Sanofi-Aventis, Austria; Sanofi-Aventis, Bosnia & Herzegowina; Sanofi-Aventis, Belgium; Sanofi-Aventis, Costa Rica; Sanofi-Aventis, Denmark; Sanofi-Aventis, Honduras; Sanofi-Aventis, Hungary; Sanofi-Aventis, Iceland; Sanofi-Aventis, Italy; Sanofi-Aventis, Latvia; Sanofi-Aventis, Mexico; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Norway; Sanofi-Aventis, Poland; Sanofi-Aventis, Romania; Sanofi-Aventis, Slovakia; Sanofi-Aventis, El Salvador; Sanofi-Aventis Groupe, Slovenia; Sanofi-Aventis, Hong Kong


ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.